Eliquis tablets for oral suspension — Medica
Treatment or prevention of other thromboembolic-related conditions (e.g., superficial vein thrombosis, splanchnic vein thrombosis, hepatic vein thrombosis, or prophylaxis of venous thromboembolism in a high-risk patient)
Initial criteria
- Patient weighs < 35 kg
- AND Patient has tried warfarin, fondaparinux, or a low molecular weight heparin product (e.g., enoxaparin, dalteparin)
- OR Patient has been started on Eliquis tablets for oral suspension or Eliquis capsules for oral suspension for treatment of an acute thromboembolic condition
Approval duration
6 months